Category: Biomedical Engineering
-
Nanoparticles can limit inflammation by distracting the immune system
White blood cells get busy taking out the trash – it could be a lifesaver when the immune system goes haywire.
-
Early innovators: Biomedical engineering upstarts
Research spawns companies that forge advancements in numerous fields.
-
Early and often: Biomedical engineering rises
Naturally evolving collaborations and adept leaders combine to forge early breakthroughs
-
Lab-grown lung tissue could lead to new cancer, asthma treatments
A look at how Michigan Engineers created a biomaterial scaffold to help researchers from the U-M Medical School grow mature human lung tissue.
-
New grad program: Engineering education research
New program turns a researcher’s eye on engineering education in the service of better teaching, learning and diversity at U-M and beyond.
-
New U-M Robotics Building named in honor of Ford Motor Company gift
The gift will accelerate construction.
-
Regenerative med center groups top-ranked U-M areas
A new $11.7 million center at the University of Michigan aims to advance regenerative medicine to restore patients’ lost dental, facial and skull tissue.
-
‘5-D protein fingerprinting’ could help fight Alzheimer’s, Parkinson’s
In an advance that could lead to new progress against diseases like Alzheimer’s and Parkinson’s, researchers have demonstrated a technique for measuring the properties of individual protein molecules.
-
The beginning of the amniotic sac
Amnion developed from human stem cells are being studied. Understanding infertility and pregnancy loss are one area being investigated.
-
“Trojan horse” Nanoparticle can halt asthma, allergies
In an entirely new approach to treating asthma and allergies, a biodegradable nanoparticle acts like a Trojan horse, hiding an allergen in a friendly shell to convince the immune system not to attack it.
-
Cancer “decoy” shows potential for breast cancer treatment
A small, implantable device that researchers are calling a cancer “super-attractor” could eventually give doctors an early warning of relapse in breast cancer patients and even slow the disease’s spread to other organs in the body.
-
Joerg Lahann
University of Michigan Biointerfaces Institute director Joerg Lahann knew from a young age that he wanted to be a chemist.